Drawing for OBI PHARMA

USPTO serial 86014025

OBI PHARMA

Reviewed by CopyMark Law Group

Reg. 4737391Status 800Registered
Filing date
Status date
Registration date
May 19, 2015
Examiner
WIENER, MICHAEL
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with OBI PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael T. Smith

Michael T. Smith Birch, Stewart, Kolasch & Birch, LLP2600 Park Tower Drive, Suite 600Vienna, VA 22180United States

Goods and services

ClassDescriptionStatusFirst use
005[ Antibiotic preparations; Antibiotics; ] Anti-cancer preparations; [ Anti-infectives; Anti-inflammatories; ] Biological preparations for the treatment of cancer; Chemical reagents for medical or veterinary purposes; [ Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic preparations for medical purposes; Diagnostic radiopharmaceutical preparations; Diagnostic reagents for medical use; Diagnostic reagents and contrast media for medical use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; ] Gastro-intestinal treatment preparations; [ In-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; Medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents for the analysis of body fluids; ] Medicinal preparations for the treatment of infectious diseases and for using in oncology; [ Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; ] Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; [ Reagents and media for medical and veterinary diagnostic purposes; ] Reagents for medical use; Vaccine adjuvants; Vaccine preparations; Vaccine stabilizers; VaccinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 21, 2026NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Feb 21, 2026RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Feb 21, 202689AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Feb 19, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 19, 2025E89RTEAS SECTION 8 & 9 RECEIVED—
May 19, 2024REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Mar 27, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 27, 2024EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Mar 27, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 27, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 27, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 2, 2022NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Apr 2, 20228.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Apr 2, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 24, 2021ES8RTEAS SECTION 8 RECEIVED—
May 19, 2020REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 2, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 19, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 3, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 3, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 11, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 26, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 20, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 15, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 15, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 15, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 16, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 16, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 16, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 9, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 9, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 4, 2014ALIEASSIGNED TO LIE—
Jun 25, 2014ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 21, 2014GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 21, 2014GNSLLETTER OF SUSPENSION E-MAILED—
Mar 21, 2014CNSLSUSPENSION LETTER WRITTEN—
Mar 21, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 20, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 20, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 6, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 6, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 6, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 31, 2013DOCKASSIGNED TO EXAMINER—
Aug 7, 2013TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Aug 7, 2013PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Aug 6, 2013PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jul 25, 2013MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 24, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 22, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance